NARA Discovery
Article Details
← Back to Search Results
Journal Article

Cloning and expression of two anti‐lipopolysaccharide factors in Eriocheir hepuensis under Vibrio alginolyticus ‐induced stress

Tianjiao Ren; Jinxia Liu; Ke Liu; Zining Zhang; Zihang Ma; Solomon F. Dan; Zhenyu Lan; Min Lu; Huaiyi Fang; Yan Zhang; Peng Zhu; Yongyan Liao
Journal of Fish Biology · Vol. 102, Issue 2 · pp. 349-357 · 2023

Abstract

Anti‐lipopolysaccharide factors (ALFs) are small basic proteins that exhibit broad‐spectrum antiviral properties and antibacterial activity. In this research, we cloned and studied two Eriocheir hepuensis ALFs, EhALF2 and EhALF3. The results showed that the open reading frame lengths of EhALF2 and EhALF3 were 363 and 372 bp, encoding 120 and 123 amino acids, respectively. Their sequences both contained an Lipopolysaccharide‐binding (LPS) domain and were highly similarity to other crab ALFs. qRT–PCR showed that EhALF2 and EhALF3 were detected in nine examined tissues and were expressed the highest in the haemocytes. After challenge with Vibrio alginolyticus , in the hepatopancreas, the expression levels of EhALF2 and EhALF3 reached the highest levels at 48 and 3 h, respectively. In the heart, the expression levels of the two genes were highest at 12 h. These results indicate that EhALF2 and EhALF3 could participate in the resistance of E. hepuensis to V. alginolyticus stress within a short time. They have potential applications in the study of environmental stress markers and disease‐resistance factors in E. hepuensis .

Bibliographic Information

JournalJournal of Fish Biology
PublisherWiley
Publication Date2023-02-01
Publication Year2023
Volume102
Issue2
Pages349-357
Document TypeJournal Article
Print ISSN0022-1112
eISSN1095-8649
DOI10.1111/jfb.15261
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/10958649
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.